BlackRock Amends Eli Lilly Stake, Signals Continued Confidence
Ticker: LLY · Form: SC 13G/A · Filed: Jan 29, 2024 · CIK: 59478
| Field | Detail |
|---|---|
| Company | Eli Lilly & Co (LLY) |
| Form Type | SC 13G/A |
| Filed Date | Jan 29, 2024 |
| Risk Level | low |
| Sentiment | neutral |
Complexity: simple
Sentiment: neutral
Topics: institutional-ownership, amendment, passive-investment
TL;DR
**BlackRock still holds a big chunk of Eli Lilly, good sign for stability.**
AI Summary
BlackRock Inc. filed an amended SC 13G/A on January 29, 2024, indicating its ownership of Eli Lilly and Company's common stock as of December 31, 2023. This amendment (Amendment No. 13) updates their previous disclosures, showing BlackRock continues to be a significant institutional holder. This matters to investors because large institutional ownership by firms like BlackRock can signal confidence in the company's long-term prospects and can influence stock stability.
Why It Matters
This filing confirms BlackRock's ongoing substantial investment in Eli Lilly, which can be seen as a vote of confidence from a major institutional investor.
Risk Assessment
Risk Level: low — This filing is routine and indicates stable institutional ownership, posing minimal risk to investors.
Analyst Insight
Investors should note BlackRock's continued significant stake as a sign of institutional confidence, but this filing alone doesn't suggest immediate action. It's a routine update on a long-term holding.
Key Players & Entities
- BlackRock Inc. (company) — the entity filing the SC 13G/A
- ELI LILLY AND COMPANY (company) — the issuer whose securities are being reported
- December 31, 2023 (date) — the date of the event requiring the filing
- January 29, 2024 (date) — the date the SC 13G/A was filed
FAQ
What type of filing is this document?
This document is an SC 13G/A, which is an amendment to a Schedule 13G filing, as indicated by 'FORM TYPE: SC 13G/A' and 'Amendment No: 13'.
Who is the filer of this SC 13G/A?
The filer of this SC 13G/A is BlackRock Inc., as stated under 'FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: BlackRock Inc.'.
Which company's securities are the subject of this filing?
The securities of ELI LILLY AND COMPANY are the subject of this filing, as indicated by 'SUBJECT COMPANY: COMPANY CONFORMED NAME: ELI LILLY & Co' and 'Name of Issuer) ELI LILLY AND COMPANY'.
What was the date of the event that required this filing?
The date of the event which required the filing of this statement was December 31, 2023, as specified in the filing.
What is the CUSIP number for the securities mentioned in this filing?
The CUSIP number for the Common Stock of ELI LILLY AND COMPANY is 532457108, as listed in the filing.
Filing Details
This Form SC 13G/A (Form SC 13G/A) was filed with the SEC on January 29, 2024 regarding ELI LILLY & Co (LLY).